Additional file 8 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer

  • Perry D Moerland (Contributor)
  • Simone Borgoni (Contributor)
  • Stefan Wiemann (Contributor)
  • Maryam Soleimani Dodaran (Contributor)
  • Antoine H C van Kampen (Contributor)
  • Emre Sofyall (Contributor)
  • Pernette J. Verschure (Contributor)

Dataset / Software

Description

Additional file 8. Survival analysis using risk score. Results of survival analysis of the multi-locus signature using the risk score corrected for selected clinical variables in ER+/HER2-, TAM and AI cohorts.
Date made available1 Jan 2020
Publisherfigshare Academic Research System

Cite this